Concepedia

Surgical Outcomes After Neoadjuvant Chemotherapy and Ipilimumab for Non-Small Cell Lung Cancer

Chi‐Fu Jeffrey Yang, Frances McSherry, Nicholas R. Mayne, Xiaofei Wang, Mark F. Berry, Betty C. Tong, David H. Harpole, Thomas A. D’Amico, Jared D. Christensen, Neal Ready,

The Annals of Thoracic Surgery · 2017 · 121 citations · 8 references

DOIFull text

Open access

Concepts

References

8

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

James Larkin, Vanna Chiarion‐Sileni, René González et al. · New England Journal of Medicine · 2015 · 8.1K citations · Full text

, , +17

A Randomized Trial Comparing Preoperative Chemotherapy Plus Surgery with Surgery Alone in Patients with Non-Small-Cell Lung Cancer

R. Rosell, José Gómez‐Codina, Carlos Camps et al. · New England Journal of Medicine · 1994 · 1.3K citations · Full text

, , +13

A Randomized Trial Comparing Perioperative Chemotherapy and Surgery With Surgery Alone in Resectable Stage IIIA Non-Small-Cell Lung Cancer

Jack A. Roth, Frank V. Fossella, R. Komaki et al. · JNCI Journal of the National Cancer Institute · 1994 · 1.1K citations

, , +13

Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study

Thomas J. Lynch, Igor Bondarenko, Alexander Luft et al. · Journal of Clinical Oncology · 2012 · 1K citations · Full text

, , +17

Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study

Matthew D. Hellmann, Naiyer A. Rizvi, Jonathan W. Goldman et al. · The Lancet Oncology · 2016 · 961 citations · Full text

, , +13